Patents Assigned to Tulane University Health and Sciences Center
  • NOVEL HIV-2 ISOLATE
    Publication number: 20140234332
    Abstract: The invention provides a novel strain of HIV-2 capable of causing immunodeficiency. The invention also provides compositions comprising the nucleic acids and polypeptides characteristic of this HIV-2 virus, antibodies specific for this HIV-2 virus, methods of using these compositions, and methods of detecting HIV-2 virus.
    Type: Application
    Filed: April 28, 2014
    Publication date: August 21, 2014
    Applicant: Tulane University Health and Sciences Center
    Inventors: Stephen M. Smith, Preston A. Marx, JR.
  • Pathogenic west african human immunodeficiency virus type 2 (HIV-2) group F isolate
    Patent number: 8747862
    Abstract: The claimed invention is directed toward an HIV-2 isolate designated NWK08F, including variants, and isolated proteins and nucleotides obtained from said isolates.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: June 10, 2014
    Assignee: Tulane University Health Sciences Center
    Inventors: Stephen M. Smith, Preston A. Marx
  • METHODS FOR TREATING DIABETES
    Publication number: 20120027729
    Abstract: Transplantation of multipotent stromal cells (MSCs) into diabetic mice lowers blood sugar, increases blood insulin levels, increases the number and size of islets, and improves renal pathology. Accordingly, the invention provides methods for treating or preventing diabetes by administering isolated MSCs. The invention also provides methods for treating or preventing complications which arise from diabetes, including diabetic nephropathy, by transplanting isolated MSCs.
    Type: Application
    Filed: April 27, 2007
    Publication date: February 2, 2012
    Applicant: Tulane University Health Sciences Center
    Inventors: Darwin J. Prockop, Ryang Hwa Lee, Min Jeong Seo
  • Enhanced growth of adult stem cells with Dkk-1
    Patent number: 7485460
    Abstract: The present invention encompasses methods and compositions for enhancing the growth of adult marrow stromal cells.
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: February 3, 2009
    Assignee: Tulane University Health Sciences Center
    Inventors: Darwin Prockop, Ichiro Sekiya, Carl Gregory, Jeffrey Spees, Jason Smith, Radhika Pochampally
  • ISOLATED POPULATION OF RAPIDLY PROLIFERATING MARROW STROMAL CELLS FOR ENHANCED IN VIVO ENGRAFTMENT
    Publication number: 20080299097
    Abstract: Multipotent stromal cells “MSCs” have been described as consisting of at least two populations of cells, rapidly self-renewing stem cells (RS-MSCs), and larger, slowly replicating cells (mMSCs). The present invention provides methods for enhancing engraftment of MSCs in vivo by administering an enriched fraction of RS-MSCs that express certain cell surface markers.
    Type: Application
    Filed: November 8, 2007
    Publication date: December 4, 2008
    Applicant: Tulane University Health Sciences Center
    Inventors: Darwin J. Prockop, Ryang Hwa Lee